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colonoscopy (p = 0.026) were independent predictors of 
compliance with screening recommendations.  Conclusion: 
Our survey has identified critical factors deterring compli-
ance with colorectal cancer screening recommendations. 
This will help to direct future campaigns in order to increase 
participation in colorectal cancer screening. 
 Copyright © 2010 S. Karger AG, Basel 
 Introduction 
 Colorectal cancer is the third most common cancer, 
the third leading cause of cancer death, and accounts for 
approximately 10% of cancer deaths overall  [1] . Approxi-
mately 1 in 3 people who develop colorectal cancer ulti-
mately die of the disease. Early detection and removal of 
adenomatous polyps has been shown to reduce the risk 
for colorectal cancer  [2, 3] . Although no randomized con-
trolled trials or case-control studies to demonstrate the 
effectiveness of colonoscopy as a screening test on colorec-
tal cancer mortality have been performed, several cross-
sectional studies have demonstrated that screening using 
colonoscopy in asymptomatic persons with average risk 
has a higher sensitivity for adenomatous lesions and ear-
ly cancer than fecal occult blood test (FOBT) and sig-
moidoscopy  [2–7] . Therefore, several guidelines endorse 
 Key Words 
 Colorectal cancer   Colonoscopy   Screening 
 Abstract 
 Background: Colonoscopy in combination with endoscopic 
polypectomy has been shown to be an efficient measure for 
reducing colorectal cancer incidence. In Germany, a colorec-
tal cancer screening program based on colonoscopy for in-
dividuals aged 55 and above was introduced in 2002. How-
ever, for largely unknown reasons, participation rates remain 
low. The purpose of this study was to identify factors influ-
encing compliance with colorectal cancer screening.  Meth-
ods: A structured survey of 239 individuals aged 55–79 years 
was performed. Statistical analysis included   2 test, t test, 
principal component analysis, and logistic regression.  Re-
sults: 56% of previously screened, but only 26% of non-
screened individuals had received a recommendation to 
 undergo screening colonoscopy. 50% of the non-screened 
believed a screening colonoscopy should only be performed 
in case of complaints. Univariate analysis identified partici-
pation in any secondary prevention measures (p  ! 0.001), 
concerns about colonoscopy (p  ! 0.012), and knowledge 
about colorectal cancer (p  ! 0.001) as critical issues distin-
guishing between groups. Multivariate analysis revealed 
that secondary prevention (p  ! 0.001) and concerns about 
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colonoscopy every 10 years as the preferred screening 
measure in average-risk individuals  [8–11] . In Germany, 
a nationwide colonoscopy-based screening program was 
enacted in 2002 starting at the age of 55.
 The German screening program is well documented 
 [12] . In 2006, 529,916 individuals underwent screening 
colonoscopy within the program. 98.4% of the colonos-
copies were documented as complete. A total of 5,240 as-
ymptomatic colorectal cancers, in the majority of cases in 
a favorite tumor stage, were detected. Altogether, in 2006, 
145,539 polypectomies were performed and 6.7% of 
screeners revealed an advanced adenoma (size  6 1 cm, 
villous architecture, high-grade intestinal neoplasia). 
The overall complication rate with 2.6 per 1,000 colonos-
copies was low. Despite the high efficacy and safety of 
screening, colonoscopy acceptance within the general 
population remains low with cumulative participation 
rates of 11.2 and 12.7% of eligible men and women, re-
spectively, between 2003 and 2006. Within a time frame 
of 10 years a total participation rate of 20–30% has been 
estimated.
 As compliance has been found to be the single most 
important determinant of effectiveness of screening pro-
grams  [13] , identifying factors influencing acceptance of 
screening colonoscopy is essential in order to increase 
adherence to the German program. This survey identifies 
demographic factors and determinants of participation 
in screening colonoscopy in uni- and multivariate analy-
ses. These results will help to focus campaigns intending 
to raise participation rates in colonoscopy screening.
 Materials and Methods 
 Development and Structure of the Questionnaire 
 The survey assessed demographic characteristics, knowledge 
about and factors influencing adherence to colorectal cancer 
screening. For the construction of the questionnaire, surveys 
from other studies  [14–16] were reviewed and open interviews 
with primary physicians, internists, and gastroenterologists about 
factors influencing participation in colonoscopy screening were 
performed. A first version of the questionnaire was developed 
which contained a wide array of potentially influencing factors. 
In order to refine the set of questions and test for understanding 
as well as practicability of the questionnaire, a pilot survey with 
30 interviews was conducted. The results of the pilot study were 
used to modify questions and to calculate the sample size needed. 
The final version of the questionnaire consisted of 63 items cover-
ing such topics as (1) knowledge about colorectal cancer and 
colorectal cancer screening, (2) attitude to healthy lifestyle and 
prevention, (3) colonoscopy-related questions as well as (4) demo-
graphic questions. All questionnaires contained the same ques-
tions except for some of the colonoscopy-related questions, which 
were modified according to the individual status of having under-
gone screening colonoscopy. Participants with previous screen-
ing colonoscopies were asked which factors had influenced their 
decision to undergo screening colonoscopy, whereas those with-
out screening colonoscopies were asked for factors responsible for 
their non-participation. The full questionnaire will be made 
available upon request.
 Identification of Study Subjects, Data Collection and Analysis 
 To plan sample size, results from 30 test interviews were used. 
The average effect size found between persons who previously had 
a screening colonoscopy and those who did not was Cohen’s d = 
0.35. In a setting of   = 0.05 and   = 0.20, each group was calcu-
lated to require a number of 102 interviews. Random-digit dialed 
telephone surveys were performed in the city and surrounding 
area of Munich, Germany (area code 89), in July and August 2007. 
A total of 2,619 telephone numbers were dialed until the sample 
size in each group was sufficient. In case no connection could be 
established, the same number was dialed again later for up to five 
times. Interviews were only started if the respondent was between 
55 and 79 years of age. Of the 728 persons agreeing to proceed 
with the interview, 308 (42%) were between 55 and 79 years of age. 
The interviews lasted between 7 and 10 min. Answers were docu-
mented electronically during the interviews (ttCall Version 3.0; 
Tribe Technologies, Frankfurt, Germany).
 Statistical Analysis 
 Statistical analysis was performed using SPSS Version 16.0 
(SPSS, Inc., Chicago, Ill., USA). Because the study aimed at com-
paring individuals with and without prior screening colonoscopy, 
group membership served as independent variable in a series of 
  2 tests with demographic variables as dependent variables. Age 
differences were analyzed by t test for independent samples. In 
order to identify factors for non-participation in the screening 
colonoscopy program, differences in all items were compared be-
tween both groups. Prior to analysis, answers to questions with 
4-point-rating scales were recoded to obtain a dichotomous an-
swer. The answer categories ‘totally disagree’ and ‘disagree’ were 
combined as well as the answer categories ‘agree’ and ‘fully agree’. 
For a principal component analysis (PCA) of uncorrelated factors 
a Varimax rotation was performed. Scores of the resulting factors 
as well as knowledge were compared between the groups. Finally, 
group membership was predicted with scores of the factors and 
knowledge using logistic regression. This analysis was conducted 
to compare the specific value of each predictor controlling the 
influence of all other predictors.
 Results 
 Of 1,786 individuals approached by telephone, 308 be-
tween 55 and 79 years of age agreed to participate and 
completed the survey by structured telephone interview. 
Of these, 136 were without previous screening colonos-
copy (group A), 103 had previously been screened by 
colonoscopy (group B), and 55 had undergone a colonos-
copy for diagnostic reasons. These 55 along with 14 par-
 Ziegler /Schubring-Giese /Bühner /Kolligs Digestion 2010;81:120–126122
ticipants with a personal history of colorectal cancer or 
chronic inflammatory bowel disease were excluded from 
further analysis. The median age of both groups was 66 
years (range 55–79). There was no significant difference 
in sex distribution and health insurance status between 
the two groups ( table 1 ). However, individuals without 
prior screening colonoscopy were more likely to have a 
higher degree of education and to be employed compared 
to the screened group (p = 0.012 and p = 0.013, respec-
tively). Remarkably, only 80% of non-screened compared 
to 95% of screened individuals reported to have a pri-
mary physician (p = 0.001). This difference in affiliation 
with a primary physician is further supported by the fact 
that only 28% of the non-screened but 58% of the screened 
group stated that they had previously received a recom-
mendation by their primary physician to undergo screen-
ing colonoscopy.
 To identify factors that influence participation in 
screening, colonoscopy questions in the four categories 
‘concerns about colonoscopy’, ‘knowledge about colo-
noscopy and colorectal cancer’, ‘attitude to health and 
healthy lifestyle’, and ‘extended personal experience 
with colorectal cancer and colonoscopy’ were posed. 
Both groups equally frequently mentioned bowel prepa-
ration as a major concern and there was no difference in 
terms of worries about unfavorable results from a colo-
noscopy ( table 2 ). The feeling of embarrassment by colo-
noscopy differed slightly between the groups (p = 0.040). 
But 23 and 36% of the non-screened versus 4 and 8% of 
the screened group reported to be afraid of discomfort 
or complications caused by colonoscopy (p  ! 0.001 and 
p  ! 0.001, respectively). However, no differences be-
tween the two groups were identified concerning knowl-
edge about colorectal cancer and efficacy of colonos-
copy-based screening. Nutrition and physical activity 
were rated as important by the majorities of both groups. 
In contrast to primary prevention, both groups differed 
significantly in terms of their attitude to secondary pre-
vention. 93 and 80% of the screened but only 47 and 46% 
of the non-screened group rated screening examina-
tions and consultations with a physician concerning 
screening as important (p  ! 0.001 and p  ! 0.001, respec-
tively). Accordingly, 96 and 93% of the screened but only 
59 and 63% of the non-screened had previously had a 
FOBT or any other screening procedures (Papanicolaou 
smear, mammography, rectal digital examination, PSA 
testing) performed (p  ! 0.001 and p  ! 0.001). In this 
context, 50% of the non-screened had an obvious mis-
conception of screening as a measure to identify sub-
clinical disease, as to their opinion a screening colonos-
copy should only be performed in case of complaints. 
Previous experience of members of their own social en-
vironment was another important influencing factor. 
We found that individuals without prior colonoscopy 
No colono-
scopy
(n = 136)
Previous screen-
ing colonoscopy
(n = 103)
p Effect-
size1
Age, years (median; range) 66; 55–79 66; 55–79 0.412 –0.11
Male/female, % 39/61 40.8/59.2 0.791 0.02
Education, %
High school or lower 48.1 64.7
College or higher 51.9 35.3 0.012 0.16
Have a primary physician2, % 80 95.1 0.001 0.22
Employment, %
Full-time/part-time 41.2 25.2
Retired 50 68.9
Other 8.8 5.8 0.013 0.19
Health insurance, %
Statutory 69.6 76.7
Private 30.4 23.3 0.243 0.08
1 Effect size for age was calculated based on t test with d values of 0.2–0.5, 0.5–0.8, 
and >0.8 indicating small, medium, and large differences, respectively. Effect sizes for 
all other variables were calculated based on 2 tests with w values of 0.1–0.3, 0.3–0.5, and 
>0.5 indicating small, medium, and large differences, respectively.
2 Seen within the last 12 months.
Table 1. Demographic data
 Acceptance of Screening Colonoscopy Digestion 2010;81:120–126 123
were less likely to be aware of a family member, friend, 
or colleague who had previously been diagnosed with 
colorectal cancer (33 vs. 46%; p = 0.060) or someone who 
had undergone colonoscopy (53 vs. 75%; p  ! 0.001) than 
members of the screened group.
 A PCA (Varimax rotation) was performed in order to 
combine items  [17] . The knowledge questions were ex-
cluded from this analysis due to different answer formats. 
This analysis identified the three factors ‘primary pre-
vention’, ‘secondary prevention’, and ‘concerns about 
colonoscopy’ ( table 3 ). The loadings of the factors prima-
ry and secondary prevention can be considered as high 
and characteristic for the assessed domains. The loadings 
for the factor concern are moderate to high. Based on the 
results of the PCA, mean scores for each of the three 
scales as well as a sum score for the knowledge questions 
were calculated ( table 4 ). Comparison of the means of 
these scores revealed a strong and significant effect con-
cerning the attitude to secondary prevention (p  ! 0.01). 
The differences were smaller but also significant for the 
scales concerns about colonoscopy (p = 0.012) and knowl-
edge (p  ! 0.001). The scale primary prevention showed no 
significant (p = 0.12) difference.
 A logistic regression was conducted with group mem-
bership as the dependent variable. Knowledge as well as 
the three PCA-based factors served as predictors. This 
multivariate analysis revealed that concerns about colo-
noscopy (p = 0.026) and participation in measures of sec-
Table 2. Factors that influence participation in screening colonoscopy (95% CI)
No colonoscopy
(n = 136)
Previous screening
colonoscopy (n = 103)
p Effect size1
Concerns about colonoscopy, %
Worried about bowel preparation 44.9; 36.5–53.3 44.7; 35.1–54.3 1.0 0.00
Embarrassed by procedure 14.3; 8.4–20.2 5.9; 1.3–10.4 0.040 0.13
Afraid of discomfort 23; 15.9–30.1 3.9; 0.2–7.6 <0.001 0.26
Afraid of complications 36.2; 28.1–44.3 7.8; 2.6–13 <0.001 0.33
Afraid of bad results 28.2; 20.6–35.8 22.3; 14.3–30.3 0.366 0.07
Knowledge, %
Correct estimation of incidence of CRC 24.3; 17.1–31.5 25.2; 16.8–33.6 0.881 0.06
Correct estimation of efficacy of early detection 16.2; 10–22.4 24.3; 16–32.6 0.140 0.10
Attitude to health, %
Nutrition is important 75.7; 68.5–82.9 84.5; 77.5–91.5 0.108 0.11
Physical activity is important 78.7; 71.8–85.6 82.4; 75–89.8 0.514 0.05
Screening is important 47.1; 38.7–55.5 93.2; 88.2–98.1 <0.001 0.49
Consultation is important 46.3; 37.9–54.7 79.6; 71.8–87.4 <0.001 0.34
Prior FOBT screening 58.5; 50.2–66.8 96.1; 92.4–99.8 <0.001 0.45
Have had other screening2 62.5; 54.4–70.6 93.2; 88.3–98.1 <0.001 0.35
Family members, friends, colleagues have had, %
Colorectal cancer 33.1; 25.2–41 45.6; 36–55.2 0.060 0.13
Colonoscopy 53.3; 44.9–61.7 74.8; 66.4–83.2 0.001 0.22
1 Effect sizes were calculated based on 2 tests with w values of 0.1–0.3, 0.3–0.5, and >0.5 indicating small, medium, and large dif-
ferences, respectively.
2 Papanicolaou smear, mammography, rectal digital examination, PSA testing.
Table 3. Grouping of factors influencing participation in screen-
ing colonoscopy
Concerns Secondary 
prevention
Primary
prevention
Nutrition 0.81
Physical activity 0.85
Screening 0.88
Consultation 0.87
Preparation 0.46
Embarrassment 0.59
Discomfort 0.50
Complication 0.73
Result 0.68
Loadings <0.30 are omitted.
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ondary prevention (p  ! 0.001), but neither knowledge 
about colorectal cancer and screening nor primary pre-
vention were significant predictors of group membership 
( table 4 ). Finally, the combined impact of all four predic-
tors for participation in screening colonoscopy was deter-
mined using Nagelkerke’s R 2  [18] . We found that all four 
variables together explained 33% of the differences be-
tween the two groups. This effect can be considered as 
large. In summary, attitude towards secondary preven-
tion and concerns about colonoscopy are the single most 
important predictors of participation in colonoscopy 
screening after controlling for mutual influence of all 
predictors.
 Discussion 
 A screening colonoscopy program was implemented 
in Germany in October 2002. So far the cumulative par-
ticipation rate of eligible average-risk persons aged  6 55 
years is low. The key to improve compliance with colorec-
tal cancer screening lies in understanding factors which 
influence participation of the population to be screened. 
Most studies analyzing the reasons for low participation 
in colon cancer screening have been performed in the 
USA  [15, 19–22] . This study was prompted by the fact that 
at the time of the survey, no data were available on factors 
influencing participation in colonoscopy screening in 
Germany. Our study identified demographic factors, 
concerns about colonoscopy, and the general attitude to 
screening as important predictors of adherence to the 
German screening recommendations.
 Our data suggest that a typical individual undergoing 
screening colonoscopy is unemployed or retired, has a 
lower degree of education and is very likely to have a pri-
mary physician. However, people with a higher education 
and those with a better health status might tend to work 
longer during their lifetimes and might therefore neither 
be in need nor have the time to regularly see a doctor and 
to undergo a screening colonoscopy. As they see a doctor 
less frequently they might have less chance to be informed 
about screening procedures and to receive the recom-
mendation to undergo colonoscopy screening. This re-
veals the pivotal role of primary physicians in informing 
and motivating patients for screening colonoscopy as has 
already been reported in previous studies  [21, 23, 24] . Our 
findings stand in contrast to other studies concerning the 
role of education in terms of participation in screening 
colonoscopy  [14, 25] . Those studies found that higher lev-
els of education correlated with higher participation rates 
in screening programs. The reason for these different 
findings is most likely due to the limited representative-
ness of all available studies. Therefore, future studies 
need to explore the role of education in this context in 
more detail.
Table 4. Mean comparison and logistic regression
Mean comparison Logistic regression
mean8SD1 p Effect size2 B SE p
Primary prevention no colonoscopy 3.1580.82 0.12 –0.22 0.18 0.17 0.30
colonoscopy 3.3280.72
Secondary prevention no colonoscopy 2.5781.08 <0.0013 –0.95 1.18 0.20 <0.001
colonoscopy 3.5880.68
Concerns no colonoscopy 1.9480.83 0.0123 0.30 –0.42 0.19 0.026
colonoscopy 1.7280.54
Knowledge no colonoscopy 3.0881.12 <0.001 –0.48 0.19 0.16 0.243
colonoscopy 3.6281.07
SD = Standard deviation; d = effect size for the difference between both groups (standardized on total SD); B = regression weight; 
SE = standard error.
1 Potential min./max. values for concerns, secondary prevention, primary prevention 1.0/4.0, and for knowledge 0.0/6.0.
2 Effect sizes were calculated based on t test with d values of 0.2–0.5, 0.5–0.8, and >0.8 indicating small, medium, and large differ-
ences, respectively.
3 Corrected for inhomogeneous variances.
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 An association between participation in screening 
colonoscopy and other measures of cancer screening has 
also been reported previously. Several studies have re-
ported that women having undergone a Papanicolaou 
smear and a mammography within the past year were 
more likely to having had a screening colonoscopy per-
formed  [26–28] . Interestingly, there was no significant 
difference between both groups in terms of primary pre-
vention and healthy lifestyle, an attitude that usually is 
independent of consultations with the primary physi-
cian. However, the effect size indicates that individuals 
who have undergone colonoscopy pay greater attention to 
primary prevention.
 Perception of colonoscopy in the group of persons who 
had never before been screened was worse than in the 
group of persons who had previously undergone screen-
ing colonoscopy. This suggests that information about 
the colonoscopic procedure itself in order to remove ir-
rational fears of discomfort and complications is an im-
portant issue influencing participation in colorectal can-
cer screening. In contrast, embarrassment by colonosco-
py and worries about a potentially unfavorable diagnosis 
were not rated differentially between both groups. How-
ever, similar as in other reports, our survey also identified 
concerns about large bowel preparation prior to colonos-
copy as a major deterrent irrespectively of the colonos-
copy status  [19, 29] . This clearly demonstrates that de-
tailed information about the endoscopic procedure, the 
opportunity of analgo-sedation, and the low risk of com-
plications should be openly discussed in order to improve 
the perception of colonoscopy in the public.
 To which extent the results of this survey including the 
sample’s representativeness regarding demographic vari-
ables can be generalized to other areas of Germany can 
only be established empirically. Therefore, future studies 
should draw larger samples and perform interviews in 
different regions of Germany. Furthermore, larger stud-
ies would be able to investigate the influence of gender as 
has been reported before  [30] . We addressed potential in-
fluencing factors with a relatively small number of items 
in order to receive a high compliance with the survey. 
This might be associated with a small inconsistency. 
Consequently, future studies should ideally lengthen the 
survey to increase reliability  [31] . However, this might re-
sult in lower rates of completed interviews, which in turn 
might represent a new confounding factor. Of the 1,786 
individuals approached by telephone, only 728 agreed to 
complete the interview. This rate might be viewed as low 
and suspected to confound the results. However, empiri-
cal evidence suggests that the response rate does not neg-
atively affect the accuracy of a survey  [32] . The form of 
questioning is another critical issue. In this study, tele-
phone interviews were used which might be more prone 
to incorrect or distorted answers than face-to-face inter-
views. Consequently, future research should invest some 
effort into replicating findings using different question-
ing formats.
 The reasons for the low adherence to screening colo-
noscopy in Germany have not been well understood so 
far. Our study identified previous participation in other 
measures of secondary prevention and concerns about 
colonoscopy as independent critical factors deterring 
from screening colonoscopy. Together with the attitude 
to primary prevention and knowledge about colorectal 
cancer, these factors explain 33% of the differences be-
tween the groups of previously screened and unscreened 
people. This suggests that future campaigns aiming at 
increasing the adherence to the German colonoscopy 
screening program and most likely also in other coun-
tries should actively discuss the frequent concerns about 
colonoscopy such as bowel preparation, pain and dis-
comfort during colonoscopy, as well as the fear of com-
plications. Except for bowel preparation, information 
about sedation during colonoscopy and the very low rate 
of severe complications should help increase the reputa-
tion of colonoscopy. Moreover, primary care physicians 
have a very central role in guiding their patients to mea-
sures of secondary prevention including colonoscopy. 
Appreciation of this role of primary physicians to inform 
and motivate their patients to screening colonoscopy 
should be accompanied by appropriate compensations 
for invested time and effort.
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